Oncology is a rapidly evolving field. Recent research in genetic biomarkers and targeted drug development has led to significant improvements in the care of patients with acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). The CATALYST initiative is an online learning tool for clinicians and patients interested in the management of AML and CLL. By compiling up-to-date information on treatment options, prognosis, and genetic profiling advances for AML and CLL, we aim to provide users with a convenient resource that improves clinical outcomes and quality of life for patients. Through participation in our online offerings and exploration of the Clinician Toolkit, our goal is to empower healthcare providers to personalize therapy based on genetic and patient-specific factors. Our Patient Toolkit is a handy resource that educates patients about their disease and empowers them to engage in their healthcare decisions.
About Med Learning Group
Med Learning Group, is a full-service, accredited medical education company. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for both the patient and the practitioner.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive, and patient-centric in nature. We apply adult learning theory and principles to our programs and, more importantly, understand the nuances of our specialty audiences. We design programs for physicians, nurses, pharmacists, and other healthcare practitioners and have a deep understanding of how to educate both specialty audiences and general practitioners. The mission of Med Learning Group is to design educational activities for healthcare practitioners that increase competence, change behavior, and optimize patient care. The major focus of our education is the creation of innovative and interactive educational programs designed with scientific rigor, fair balance, and evidence-based content.